Skip to main content

Sippican Capital Advisors

SEC CIK
0001557406
Latest filing
Jul 22, 2026

ABBV holding history

AbbVie Inc. in every 13F filed by Sippican Capital Advisors, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABBV overviewAll 13F holders of ABBVFull Q2 2026 holdings

Shares (Q2 2026)
12,947
Value
$3.26M
% of portfolio
2.0%
Quarters held
22
Since Q1 2021
Holdings of ABBV by Sippican Capital Advisors, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202612,947$3.26M2.0%−75−0.6%ReducedHolders
Q1 202613,022$2.83M1.9%−437−3.2%ReducedHolders
Q4 202513,459$3.08M2.0%−476−3.4%ReducedHolders
Q3 202513,935$3.23M2.1%−75−0.5%ReducedHolders
Q2 202514,010$2.60M1.9%−10−0.1%ReducedHolders
Q1 202514,020$2.94M2.2%−25−0.2%ReducedHolders
Q4 202414,045$2.50M1.8%−745−5.0%ReducedHolders
Q3 202414,790$2.92M2.0%−670−4.3%ReducedHolders
Q2 202415,460$2.65M2.1%−432−2.7%ReducedHolders
Q1 202415,892$2.89M2.3%−800−4.8%ReducedHolders
Q4 202316,692$2.59M2.0%+350+2.1%AddedHolders
Q3 202316,342$2.44M2.2%+50+0.3%AddedHolders
Q2 202316,292$2.20M2.0%−96−0.6%ReducedHolders
Q1 202316,388$2.61M2.5%−145−0.9%ReducedHolders
Q4 202216,533$2.67M2.6%−60−0.4%ReducedHolders
Q3 202216,593$2.23M2.3%−35−0.2%ReducedHolders
Q2 202216,628$2.55M2.5%−3,410−17.0%ReducedHolders
Q1 202220,038$3.25M2.7%−115−0.6%ReducedHolders
Q4 202120,153$2.73M2.3%−1,474−6.8%ReducedHolders
Q3 202121,627$2.33M2.0%+100.0%AddedHolders
Q2 202121,617$2.44M2.1%+48+0.2%AddedHolders
Q1 202121,569$2.33M2.2%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.